Literature DB >> 3873268

Antidromic activation of dorsal raphe neurons from neostriatum: physiological characterization and effects of terminal autoreceptor activation.

S F Sawyer, J M Tepper, S J Young, P M Groves.   

Abstract

Three types of neurons, distinguished on the basis of their spontaneous firing rates and patterns, extracellularly recorded waveforms and responses to neostriatal stimulation, were observed in the dorsal raphe nucleus in urethane-anesthetized rats. Type 1 neurons (presumed to be serotonergic) fired spontaneously from 0.1 to 3 spikes/s in a regular pattern, with initial positive-going bi- or triphasic action potentials. Type 1 cells exhibited long-latency antidromic responses to neostriatal stimulation (mean +/- S.E.M. 24.9 +/- 0.3 ms) that sometimes occurred at discrete multiple latencies, and supernormal periods persisting up to 100 ms following spontaneous spikes. Type 2 cells fired spontaneously in an irregular, somewhat bursty pattern from 0 to 2 spikes/s with initial negative-going biphasic spikes, and were antidromically activated from neostriatal stimulation at shorter latencies than Type 1 cells (21.8 +/- 0.9 ms). Type 3 cells were characterized by initial positive-going biphasic waveforms and displayed a higher discharge rate (5-30 spikes/s) than Type 1 or Type 2 cells. Type 3 cells could not be antidromically activated from neostriatal stimulation. The relatively long conduction time to neostriatum of the Type 1 presumed serotonergic neuron is discussed with respect to previous interpretations of the synaptic action of serotonin in the neostriatum. In conjunction with these antidromic activation studies, the neurophysiological consequences of serotonergic terminal autoreceptor activation were examined by measuring changes in the excitability of serotonergic terminal fields in the neostriatum following administration of the serotonin autoreceptor agonist, 5-methoxy-N,N-dimethyltryptamine (5-MeODMT). The excitability of serotonergic terminal fields was decreased by intravenous injection of 40 micrograms/kg 5-MeODMT, and by infusion of 10-50 microM 5-MeODMT directly into the neostriatum. These results are interpreted from the perspective of mechanisms underlying autoreceptor-mediated regulation of serotonin release.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3873268     DOI: 10.1016/0006-8993(85)90385-3

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  7 in total

1.  Control of serotonergic function in medial prefrontal cortex by serotonin-2A receptors through a glutamate-dependent mechanism.

Authors:  R Martín-Ruiz; M V Puig; P Celada; D A Shapiro; B L Roth; G Mengod; F Artigas
Journal:  J Neurosci       Date:  2001-12-15       Impact factor: 6.167

2.  Dorsal raphé stimulation modifies striatal-evoked antidromic invasion of nigral dopaminergic neurons in vivo.

Authors:  F Trent; J M Tepper
Journal:  Exp Brain Res       Date:  1991       Impact factor: 1.972

3.  Reward-dependent modulation of neuronal activity in the primate dorsal raphe nucleus.

Authors:  Kae Nakamura; Masayuki Matsumoto; Okihide Hikosaka
Journal:  J Neurosci       Date:  2008-05-14       Impact factor: 6.167

4.  Lateral habenula and hippocampus: a complex interaction raphe cells-mediated.

Authors:  G Ferraro; M E Montalbano; P Sardo; V La Grutta
Journal:  J Neural Transm (Vienna)       Date:  1997       Impact factor: 3.575

5.  Coding of task reward value in the dorsal raphe nucleus.

Authors:  Ethan S Bromberg-Martin; Okihide Hikosaka; Kae Nakamura
Journal:  J Neurosci       Date:  2010-05-05       Impact factor: 6.167

6.  Control of dorsal raphe serotonergic neurons by the medial prefrontal cortex: Involvement of serotonin-1A, GABA(A), and glutamate receptors.

Authors:  P Celada; M V Puig; J M Casanovas; G Guillazo; F Artigas
Journal:  J Neurosci       Date:  2001-12-15       Impact factor: 6.167

7.  Control of the serotonergic system by the medial prefrontal cortex: potential role in the etiology of PTSD and depressive disorders.

Authors:  Pau Celada; M. Victoria Puig; Raúl Martín-Ruiz; Josep M. Casanovas; Francesc Artigas
Journal:  Neurotox Res       Date:  2002 Aug-Sep       Impact factor: 3.911

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.